Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Compensation Expense

The table below summarizes the impact of recording stock-based compensation expense in the Condensed Consolidated Statements of Operations and Comprehensive Loss during the three and six months ended June 30, 2019 and 2018:



	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Cost of goods sold	$	179	$	267	$	406	$	503
Operating expenses:
Research and development	331		362		663		695
Clinical and regulatory affairs	187		256		373		432
Marketing and sales	685		706		1,394		1,820
General and administrative	1,141		2,674		2,048		3,836
Total operating expenses	2,344		3,998		4,478		6,783
Total	$	2,523	$	4,265	$	4,884	$	7,286